Biologically active human islet amyloid polypeptide/amylin in transgenic mice

European Journal of Endocrinology

Volumn 136, Issue 1, 1997, Pages 107-113

  Van Hulst, Karen L ^a   Born, Walter ^b   Muff, Roman ^b   Oosterwijk, Cor ^a   Blankenstein, Marinus A ^a   Lips, Cornelis J M ^a   Fischer, Jan A ^b   Höppener, Jo W M ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; CYCLIC AMP; GENE PRODUCT; PANCREAS EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; GENE OVEREXPRESSION; HYPERGLYCEMIA; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORTHERN BLOTTING; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TRANSGENIC MOUSE;

EID: 0031054552     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360107     Document Type: Article

References (34)

1. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD & Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans in the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proceedings of the National Academy of Sciences of the USA 1987 84 3881-3885.
2. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB & Reid KBM. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proceedings of the National Academy of Sciences of the USA 1987 84 8628-8632.
3. Kanatsuka A, Makino H, Ohsawa H, Tokuyama Y, Yamaguchi T, Yoshida S et al. Secretion of islet amyloid polypeptide in response to glucose. FEBS Letters 1989 259 199-201.
4. Van Hulst KL, Hackeng WHL, Höppener JWM, Van Jaarsveld BC, Nieuwenhuis MG, Blankenstein MA et al. An improved method for the determination of islet amyloid polypeptide levels in plasma. Annals of Clinical Biochemistry 1994 31 165-170.
5. Van Hulst KL, Nieuwenhuis MG, Höppener JWM, Lips CJM & Blankenstein MA. Lack of islet amyloid polypeptide/amylin-immunoreactivity in urine collected from healthy volunteers after ingestion of a carbohydrate-rich meal. Experimental and Clinical Endocrinology 1996 104 177-179.
6. Ohsawa H, Kanatsuka A, Yamaguchi T, Makino H & Yoshida S. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochemical and Biophysical Research Communications 1989 160 961-967.
7. Ar'Rajab A & Ahren B. Effects of amidated rat islet amyloid polypeptide on glucose-stimulated insulin secretion in vivo and in vitro in rats. European Journal of Pharmacology 1991 192 443-445.
8. Dégano P, Silvestre RA, Salas M, Pieró E & Marco J. Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regulatory Peptides 1993 43 91-96.
9. Wagoner PK, Chen C, Worley JF, Dukes ID & Oxford GS. Amylin modulates beta-cell glucose sensing via effects on stimulussecretion coupling. Proceedings of the National Academy of Sciences of the USA 1993 90 9145-9149.
10. Leighton B & Cooper GJS. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 1988 335 632-635.
11. Cooper GJS, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Howland K et al. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proceedings of the National Academy of Sciences of the USA 1988 85 7763-7766.
12. Koopmans SJ, van Mansfeld ADM, Jansz HS, Krans HMJ, Radder JK, Frölich M et al. Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues. Diabetologia 1991 34 218-224.
13. Young AA, Rink TJ & Wang MW. Dose-response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRPα) in the fasted anesthetized rat. Life Sciences 1993 52 1717-1726.
14. Clark A. Islet amyloid: An enigma of type 2 diabetes. Diabetes and Metabolism Reviews 1992 8 117-132.
15. Oosterwijk C, Höppener JWM, van Hulst KL & Lips CJM. Pancreatic islet amyloid formation in patients with non-insulin-dependent diabetes mellitus. Implication for therapeutic strategy. International Journal of Pancreatohgy 1995 18 7-14.
16. Westermark P, Engström U, Johnson KH, Westermark GT & Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proceedings of the National Academy of Sciences of the USA 1990 87 5036-5040.
17. Höppener JWM, Verbeek JS, de Koning EJP, Oosterwijk C, van Hulst KL, Visser-Vernooy HJ et al. Chronic overproduction of islet amyloid polypeptide (IAPP)/amylin in transgenic mice: Lysosomal localization of human IAPP and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 1993 36 1258-1265.
18. Höppener JWM, Oosterwijk C, van Hulst KL, Verbeek JS, Capel PJA, de Koning EJP et al. Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat and transgenic mice. Journal of Cellular Biochemistry 1994 55S 39-53.
19. Chirgwin JM, Przybyla AE, MacDonald RJ & Rutten WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979 18 5294-5299.
20. Jamal H, Bretherton-Watt D, Suda K, Ghatei MA & Bloom SR. Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin. Journal of Endocrinology 1990 126 425-429.
21. Burton KA. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochemistry 1956 62 315-323.
22. Mosselman S, Höppener JWM, Lips CJM & Jansz HS. The complete islet amyloid polypeptide precursor is encoded by two exons. FEBS Letters 1989 247 154-158.
23. Muff R, Stangl D, Born W & Fischer JA. Comparison of a calcitonin gene-related peptide receptor in a human neuroblastoma cell line (SK-N-MC) and a calcitonin receptor in a human breast carcinoma cell line (T47D). Annals of the New York Academy of Sciences 1992 657 106-116.
24. Van Hulst KL, Höppener JWM, Berends MJH, Nieuwenhuis MG, Blankenstein MA & Lips CJM. Characterization of antibodies against human islet amyloid polypeptide (IAPP)/amylin and its C-terminal flanking peptide (C-proIAPP). European Journal of Endocrinology 1994 130 (Suppl 2) 196 (Abstract).
25. Kaufmann M, Muff R, Born W & Fischer JA. Functional expression of a stably transfected parathyroid hormone/parathyroid hormone-related protein receptor complementary DNA in CHO cells. Molecular and Cellular Endocrinology 1994 104 21-27.
26. Nagamatsu S, Nishi M & Steiner DF. Biosynthesis of islet amyloid polypeptide. Elevated expression in mouse βTC3 cells. Journal of Biological Chemistry 1991 266 13737-13741.
27. Höppener JWM, Oosterwijk C, Visser-Vernooy HJ, Lips CJM & Jansz HS. Characterization of the human islet amyloid polypeptide/amylin gene transcripts: identification of a new polyadenylation site. Biochemical and Biophysical Research Communications 1992 189 1569-1577.
28. Shiomi K, Nakazato M, Miyazato M, Kangawa K, Matsuo H & Matsukura S. Establishment of hypersensitive radioimmunoassay for islet amyloid polypeptide using antiserum specific for its N-terminal region. Biochemical and Biophysical Research Communications 1992 186 1065-1073.
29. Fox N, Schrementi J, Nishi M, Ohagi S, Jin Chan S, Heisserman JA et al. Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM). FEBS Letters 1993 323 40-44.
30. D'Alessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD et al. Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes 1994 43 1457-1461.
31. Novials A, Sarri Y, Casamitjana R, Rivera F & Gomis R. Regulation of islet amyloid polypeptide in human pancreatic islets. Diabetes 1993 42 1514-1519.
32. Clark A, Edwards CA, Ostle LR, Sutton R, Rothbard JB, Morris JF et al. Localisation of islet amyloid polypeptide in lipofuscin bodies and secretory granules of human β-cells and in islets of type 2 diabetic subjects. Cell and Tissue Research 1989 257 179-185.
33. De Koning EJP, Höppener JWM, Verbeek JS, Oosterwijk C, van Hulst KL, Baker CA et al. Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans. Diabetes 1994 43 640-644.
34. De Koning EJP, Morris ER, Hofhuis FMA, Posthuma G, Höppener JWM, Morris JF et al. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. Proceedings of the National Academy of Sciences of the USA 1994 91 8467-8471.